Berard Todd, Chief Marketing Officer, has demonstrated a consistent pattern of selling shares in BioLife Solutions, Inc. (BLFS) over the past several years, as evidenced by SEC Form 4 filings. Todd has executed 33 trades, all of which involve BLFS, with a total sell value of $1,386,018.89 and no recorded purchases. Notably, 19 of these sales occurred in the most recent period, underscoring a sustained divestment trend. Significant transactions include a $255,300 sale on August 25, 2025, and a $226,700 sale on May 15, 2024, indicating substantial liquidity events. Smaller, more frequent sales, such as $7,321.22 on March 3, 2026, and $1,619.14 on May 17, 2024, suggest a methodical approach to reducing his holdings. The absence of any buy transactions, coupled with the consistent selling activity, highlights a clear bias toward divesting his position in BLFS. This pattern aligns with Todd’s role as a corporate insider, though the filings provide no indication of the specific reasons behind these transactions. The data reflects a deliberate and ongoing reduction in his stake in BioLife Solutions.
AI-assisted summary